Episodes

Episode Description: What’s the difference between menopause and perimenopause anyway? Is there such a thing as menopause misinformation? Why don’t we know more about menopause and HRT? Dr. Gillian Goddard, an endocrinologist and writer behind the Hot Flash newsletter, answers these and other important questions about menopause, debunking common myths and providing practical advice for how to talk to your doctor abou...

Brittany Chaffee talks about navigating cervical health testing, and recounts the moment she received an alarming call from her doctor, leading to years of anxiety, biopsies, and eventually, a harrowing LEEP procedure. Brittany emphasizes the importance of talking publicly about women’s health to combat shame and isolation. Show notes: ‘The powerful act of sharing our stories about women’s health.’ https://witanddeli...

Oriana Papin-Zoghbi is the co-founder of a women’s health startup called AOA Dx that is working towards early detection for ovarian cancer. Oriana talks about the challenges the company has faced in navigating the complex world of fundraising, the term ‘femtech’, and the experience of leading a startup dedicated to transforming women's health. Want to find out what's coming next on Overlooked, or learn about the back...

How much do we really know about our bodies - and did we learn it in real time, when something went wrong, or on a scroll through social media? We need accurate, credible information that is relevant to our health, and in this episode, Dr Brandi Sinkfield, an anesthesiologist and the host of the Women’s Digital Health podcast, talks about ‘health literacy’, and the intersection of health and technology, and the impac...

We still have so much to learn about the ovaries, including describing and naming parts of these organs in detail. Dr. Kathleen O’Neill talks about her work with a multidisciplinary group of researchers to map the ovaries, in order to better understand their profound implications on women’s health. Show Notes: Dr. Kathleen O'Neill at the University of Pennsylvania (https://www.pennmedicine.org/providers/profile/kathl...

Welcome to Season 2 of Overlooked, where women's health is brought to life through immersive personal storytelling and in-depth conversations. In this episode, a transition from Season 1, host Golda Arthur shares her personal story with surgical menopause, has a conversation with her mother about moving forward, and hears from a listener who sent in her story. You can send your story too - write to the show, or send ...

Endometriosis is a complex condition and journalist Gabrielle Jackson has spent most of her life dealing with it. She tells her personal story, the pervasive issue of chronic pain in women, and the medical system's historic neglect of women's health. Gabrielle Jackson is the deputy editor of The Guardian Australia, and the author of ‘Pain and Prejudice, How the Medical System Ignores Women—And What We Can Do About It...

In reporting and writing this series, I’ve become intrigued by the ovaries themselves and their underrated role in our overall health. In this episode, I talk to pioneering gynecological oncologist Dr Dianne Miller about why the ovaries are still so mysterious to us, and why we don’t talk about ovarian health more.

Another recurrence to deal with, and then a long-awaited trip to India, to see my grandmother, as the series comes to a close.

This episode hands the mic over to two other survivors of ovarian cancer - Susan Leighton, and Donna Pepin. Both Susan and Donna talk about how they're paying their survivorship forward, through advocacy.

The cancer comes back again, and Mom starts a new round of chemo. At this point, I decide I would finally go and get a genetics test done for myself. In this episode, I talk to my genetics counselor, and my sister Esther, about the results of her test and what happened next for her.

In 2020, Mom was dealing with the covid pandemic as well as cancer. After her chemotherapy treatment ended, she started on a new drug, called niraparib, to try and prevent a recurrence. She would end up back in the emergency room, but this time, it wasn’t covid, or cancer. And, I talked to Dr Tracy Brooks for a deep dive on PARB inhibitors, a relatively new class of drugs used in cancer treatment.

This cancer comes from a genetic mutation. We learn more about this, and how it works. What does that mean for how you prevent or treat this cancer? Sarah DeFeo from the Ovarian Cancer Research Alliance explains, and talks about why genetic testing is an important tool going forward.

The cancer comes back. (Remember that dandelion?) We learn that recurrence is a common feature of ovarian cancer because early detection is so difficult and there is no way to screen for it. But asking the question ‘why can’t we see it coming?’ leads me on a journey to learn more about - not the ovaries - but the fallopian tubes, and new innovations to try and get ahead of this cancer.

Caregiving, and even standing by as someone you love goes through cancer, is its own journey, and deserves its own episode. This episode features Robin Arthur, and Pamela Esposito-Amery from Tell Every Amazing Lady.

Chemotherapy begins. Walking into the chemotherapy room that first day, none of us know what to expect. Mom has a bad reaction to the drugs as she begins her treatment journey. We learn: what is chemotherapy, how does it work, and what toll does it take on the body. The episode features Dr Lana Saciragic, Gynecologic Oncologist at Nova Scotia Health Authority.

After months of vague symptoms and a battery of tests, the cancer is finally diagnosed. This episode asks, what is ovarian cancer, and why is it so hard to diagnose? Featuring Dr Lana Saciragic, Gynecologic Oncologist at Nova Scotia Health Authority.

We begin in a hospital room, in Halifax, Canada, as a difficult moment is about to unfold. An introduction to Teresa, and to ovarian cancer as she and her family experienced it.

The story of one ovarian cancer survivor, as told by her daughter, using intimate recorded conversations and audio diaries, to bring a much-overlooked cancer into the light.